![Ramaco Resources, Inc. (METC) Securities Class Action Lawsuit Update [February 9, 2026]](https://media.suewallst.com/cms-dev/METC_7c91906103.jpeg)
Ramaco Resources, Inc. (METC) Securities Class Action Lawsuit Update [February 9, 2026]
Introduction to Ramaco Resources, Inc. (METC) Securities Class Action Lawsuit

Paysafe Limited (PSFE): Lawsuit Alleges Undisclosed Credit Exposure Following 27.6% Stock Decline
Learn about securities lawsuits tied to your portfolio and recover money!
Paysafe Limited did not collapse in a blaze of scandal. It slipped. Slowly, then all at once.
A federal securities class action filed in February 2026 alleges that Paysafe Limited and certain executives made misleading statements about the company’s exposure to high-risk merchants and related credit losses. When the previously undisclosed information concerning credit exposure and merchant risk was revealed in November 2025, the market reacted swiftly. Shares fell more than 27% in a single session.
The lawsuit now asks whether the warning signs were always there and whether investors were given the full picture in time to act.
“Most PSFE shareholders never file or join the class action, which means they miss out on potential recovery funds,” said Attorney Joseph Levi.
Paysafe Limited is a global payments company operating across two reportable segments: Merchant Solutions and Digital Wallets. Its business model centers on enabling electronic payments for consumers and merchants, including customers without traditional bank accounts or credit cards.
The company’s Merchant Solutions segment processes card transactions for merchants, while its Digital Wallets segment combines legacy alternative payment services with prepaid voucher products. According to its public filings, Paysafe emphasized scale, diversification, and what it described as a strong global banking infrastructure spanning nearly 100 commercial banks across 34 countries.
In public filings leading into the class period and during 2025, Paysafe repeatedly highlighted revenue growth, organic expansion in e-commerce, and confidence in its banking relationships, an assurance that would later become central to investor claims.
At the start of the class period, Paysafe projected reported revenue growth of 5%–7% and adjusted EBITDA margin of approximately 30%–31% for full-year 2025. In March 2025, the company publicly forecast organic revenue growth of up to 8% and its filings included disclosures concerning its allowance for credit losses and merchant risk exposure.
In its annual Form 20-F, Paysafe pointed to growth in Merchant Solutions driven by higher volumes and portfolio optimization, while also highlighting its strong global banking infrastructure. Risk factors acknowledged that merchant categories could pose challenges but framed them as hypothetical future concerns rather than present realities.
The complaint alleges that behind these assurances sat a materially different situation: concentrated exposure to a single high-risk client, increasing chargeback risk tied to higher-risk Merchant Category Codes, and credit reserves that did not reflect the true level of exposure.
The alleged misstatements span most of 2025.
From March through August, Paysafe repeatedly reaffirmed its full-year guidance in quarterly press releases and Form 6-K filings. Each disclosure reiterated confidence in revenue trajectory and credit management, even as the complaint alleges the Company had concentrated exposure to a single high-risk client and higher-risk merchant categories that were not fully reflected in public disclosures.
The inflection point arrived on November 13, 2025. Before markets opened, Paysafe reported third-quarter results that missed consensus estimates, posted a sharply increased net loss, and slashed full-year guidance. The company disclosed a spike in credit loss expense and write-offs tied to an individual merchant in its Merchant Solutions segment.
During the earnings call that followed, CEO Bruce Lowthers acknowledged that a “last-minute client” shutdown caused a multi-million-dollar write-down and described challenges associated with higher-risk merchant categories that were “a little difficult to bank.”
The market’s response was immediate. Shares fell $2.80, or 27.6%, in a single day on heavy trading volume.
According to the complaint, Paysafe securities traded at artificially inflated prices throughout the class period as a result of the alleged misstatements and omissions. The stock reached a class-period high of $17.93 in March 2025 before collapsing to $7.36 following the November disclosures.
Plaintiffs contend that the corrective disclosures directly revealed previously concealed risks, namely concentrated exposure to high-risk merchants, understated credit losses, and instability in banking sponsorship, thereby establishing loss causation under the federal securities laws.
The action was filed in the U.S. District Court for the Southern District of New York under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. Named defendants include Paysafe Limited, CEO Bruce Lowthers, and CFO John Crawford. The complaint alleges scienter, asserting that senior executives had access to internal information contradicting their public statements. It further invokes the fraud-on-the-market doctrine, arguing that Paysafe shares traded in an efficient market and that investors relied on the integrity of the market price.
As of filing, the case remains at the pleading stage, with plaintiffs seeking class certification, damages, and other relief.
Retail sentiment around Paysafe appeared to shift sharply after the company’s November 13, 2025 earnings release and related disclosures. Paysafe reported a spike in credit-loss expense tied primarily to an individual merchant, disclosed write-offs in Merchant Solutions, lowered its full-year outlook, and then watched its shares fall $ 2.80, or 27.6% in a single session. Against that backdrop, the conversation across public retail-investor channels turned noticeably more skeptical, with attention focusing less on growth and more on merchant concentration, chargeback exposure, and the credibility of prior guidance.
On social-media and forum pages where PSFE investors congregate, the November release became the focal point of discussion. On social-media platforms such as X (formerly Twitter) and Stocktwits, investors circulated excerpts from the earnings call in which CEO Bruce Lowthers referenced a “last-minute client” shutdown and acknowledged that certain higher-risk merchant categories were “a little difficult to bank.” These remarks became a focal point for discussion about the company’s exposure to higher-risk merchants.
Discussion threads on Reddit communities focused on PSFE and retail trading, including r/PSFE and r/stocks, similarly focused on the magnitude of the one-day decline and the revised outlook. Many investors contrasted the earnings call disclosures with the company’s earlier messaging about maintaining a “strong global banking infrastructure.” As that conversation spread across investor forums, the sentiment arc moved from earlier optimism about growth to skepticism surrounding merchant concentration and credit-loss risk, issues that now sit at the center of the complaint’s allegations.
Sell-side analysts also moved quickly to reassess Paysafe’s outlook after the November earnings release and guidance reduction. The disclosure of merchant-related credit losses and write-downs prompted several firms to revise financial models and lower price targets as they recalibrated expectations for the company’s near-term performance.
RBC Capital Markets lowered its price target to $10 from $17 while maintaining a Sector Perform rating, citing the revised guidance and changes in revenue mix affecting profitability. UBS also reduced its target to $7 from $12 and reiterated a Sell rating as analysts incorporated the credit-loss disclosures and merchant-specific risks into their forward projections.
These revisions reflected a broader reassessment of Paysafe’s risk profile after the earnings release. The lawsuit now frames that shift as evidence that risks tied to merchant exposure and credit losses were more significant during the class period than investors were led to believe.
Paysafe’s SEC filings during the class period included repeated risk disclosures related to merchant categories, chargebacks, and banking relationships. However, the complaint alleges these warnings were framed as contingent risks rather than existing conditions.
Forms 20-F and 6-K described exposure to credit losses and outlined allowance methodologies, but plaintiffs argue those disclosures failed to capture the magnitude of concentrated risk posed by a single high-risk merchant and the resulting impact on reserves and write-offs.
Plaintiffs allege that the Company’s risk disclosures described certain risks as potential future events, when those risks were already materializing.
The Paysafe lawsuit ultimately asks a straightforward question: did the company’s public disclosures fully reflect the risks developing within its merchant portfolio?
According to the complaint, investors were presented with a narrative of steady growth and manageable credit exposure during the class period. When Paysafe later reported increased credit losses tied to a merchant relationship and lowered its guidance in November 2025, the market reacted sharply.
The litigation will now test whether those risks were already materializing—and whether investors had been given a complete picture before the stock’s sudden decline.
How to Join the Paysafe Limited (PSFE) Class Action
Disclaimer: This shareholder alert is for informational purposes only and does not constitute legal advice. Consult a qualified attorney for personalized guidance. No specific outcomes are guaranteed.
![Ramaco Resources, Inc. (METC) Securities Class Action Lawsuit Update [February 9, 2026]](https://media.suewallst.com/cms-dev/METC_7c91906103.jpeg)
Introduction to Ramaco Resources, Inc. (METC) Securities Class Action Lawsuit
![Mereo Biopharma Group Plc (MREO) Securities Class Action Lawsuit Update [February 17, 2026]](https://media.suewallst.com/cms-dev/MREO_Blog_Cover_d86629a198.jpeg)
Mereo BioPharma faces a securities class action after Phase 3 setrusumab trials failed, triggering major stock declines and investor losses.

Oracle (ORCL) Lawsuit Alleges AI Spending Fueled Massive CapEx Risks and Investor Losses